We found that treatment with recombinant VEGFA (rVEGFA) abolished the inhibitory effects of conditioned medium from shB7-H3 CRC cells on HUVEC angiogenesis when compared with control IgG treatment or no treatment (Fig. 4a–c and Supplementary Fig. S6a-c). This evidence concerns the gene VEGFA and colorectal carcinoma.